|
Nru tal-Indiċi
|
Isem Kimiku
|
Nru KE
|
Nru CAS
|
Klassifikazzjoni
|
Tikkettar
|
Limiti ta’ Konċ. Speċifiċi, Fatturi-M u ATE
|
Noti
|
|
Klassi tal-Periklu u Kodiċi(jiet) tal-Kategorija
|
Kodiċi(jiet) tad-Dikjarazzjonijiet tal-Periklu
|
Pittogramma, Kodiċi(jiet) tal-Kliem Sinjal
|
Kodiċi(jiet) tad-Dikjarazzjonijiet tal-Periklu
|
Kodiċi(jiet) Supplimentari tad-Dikjarazzjonijiet tal-Periklu
|
|
“014-052-00-7
|
silanammina, 1,1,1-trimetil-N-(trimetilsilil)-, prodotti tal-idroliżi bis-siliċe; diossidu tas-siliċju piroġeniku, amorfu sintetiku, nano, bis-superfiċe ttrattata
|
272-697-1
|
68909-20-6
|
STOT RE 2
|
H373 (pulmuni) (inalazzjoni)
|
GHS08
Twis.
|
H373 (pulmuni) (inalazzjoni)
|
EUH066”
|
|
|
|
“035-005-00-7
|
bromur tal-ammonju
|
235-183-8
|
12124-97-9
|
Ripr. 1B
Latt.
STOT SE 3
STOT RE 1
Irrit. tal-Għajnejn 2
|
H360FD
H362
H336
H372 (sistema nervuża)
H319
|
GHS08
GHS07
Dgr
|
H360FD
H362
H336
H372 (sistema nervuża)
H319”
|
|
|
|
|
“050-032-00-4
|
dibutilin bis(2-etileżanoat)
|
220-481-2
|
2781-10-4
|
Mutaġenità 2
Ripr. 1B
STOT RE 1
|
H341
H360FD
H372 (sistema immunitarja)
|
GHS08
Dgr
|
H341
H360FD
H372 (sistema immunitarja)”
|
|
|
|
|
“050-033-00-X
|
di(aċetat) tad-dibutilin
|
213-928-8
|
1067-33-0
|
Mutaġenità 2
Ripr. 1B
STOT RE 1
|
H341
H360FD
H372 (sistema immunitarja)
|
GHS08
Dgr
|
H341
H360FD
H372 (sistema immunitarja)”
|
|
|
|
|
“052-001-00-0
|
tellurju
|
236-813-4
|
13494-80-9
|
Ripr. 1B
Latt.
|
H360Df
H362
|
GHS08
Dgr
|
H360Df
H362”
|
|
|
|
|
“052-002-00-6
|
diossidu tat-tellurju
|
231-193-1
|
7446-07-3
|
Ripr. 1B
Latt.
|
H360Df
H362
|
GHS08
Dgr
|
H360Df
H362”
|
|
|
|
|
“056-005-00-3
|
tetraossidu tal-barju diboron
|
237-222-4
|
13701-59-2
|
Ripr. 1B
Toss. Akuta 4
Toss. Akuta 3
|
H360FD
H332
H301
|
GHS08
GHS06
Dgr
|
H360FD
H332
H301
|
|
inalazzjoni:
ATE = 1,5 mg/L (trabijiet jew raxx)
orali:
ATE = 100 mg/kg piż tal-ġisem”
|
|
|
“601-097-00-8
|
Propilbenżen
|
203-132-9
|
103-65-1
|
Fjam. Likw. 3
Asp. Toss. 1
STOT SE 3
Akkwatiku Kroniku 2
|
H226
H304
H335
H411
|
GHS02
GHS08
GHS07
GHS09
Dgr
|
H226
H304
H335
H411”
|
|
|
|
|
“603-243-00-6
|
2,2-dimetilpropan-1-o1, derivattiv tat-tribromo; 3-bromo-2,2-bis(bromometil)propan-1-o1
|
253-057-0
|
36483-57-5; 1522-92-5
|
Karċ. 1B
Mutaġenità 2
|
H350
H341
|
GHS08
Dgr
|
H350
H341”
|
|
|
|
|
“604-096-00-0
|
butossidu tal-piperonil (ISO); etere ta’ 2-(2-butossietossi)etil 6-propilpiperonil
|
200-076-7
|
51-03-6
|
STOT SE 3
Irrit. tal-Għajnejn 2
Akkwatiku Akut 1
Akkwatiku Kroniku 1
|
H335
H319
H400
H410
|
GHS07
GHS09
Twis.
|
H335
H319
H410
|
EUH066
|
M = 1
M = 1”
|
|
|
“604-097-00-6
|
2,4,6-tri-tert-butilfenol
|
211-989-5
|
732-26-3
|
Ripr. 1B
Toss. Akuta 4
STOT RE 2
Sens. tal-Ġilda 1B
|
H360D
H302
H373 (fwied)
H317
|
GHS08
GHS07
Dgr
|
H360D
H302
H373 (fwied)
H317
|
|
orali:
ATE = 500 mg/kg piż tal-ġisem”
|
|
|
“604-098-00-1
|
4,4’-sulfonildifenol; bisfenol S
|
201-250-5
|
80-09-1
|
Ripr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
|
“606-153-00-5
|
benżofenon
|
204-337-6
|
119-61-9
|
Karċ. 1B
|
H350
|
GHS08
Dgr
|
H350”
|
|
|
|
|
“606-154-00-0
|
kinoklamina (ISO); 2-ammino-3-kloro-1,4-naftokinon
|
220-529-2
|
2797-51-5
|
Karċ. 2
Ripr. 2
Toss. Akuta 4
STOT RE 2
Irrit. tal-Għajnejn 2
Sens. tal-Ġilda 1 A
Akkwatiku Akut 1
Akkwatiku Kroniku 1
|
H351
H361d
H302
H373 (sistema tad-demm, kliewi)
H319
H317
H400
H410
|
GHS08
GHS07
GHS09
Twis.
|
H351
H361d
H302
H373 (sistema tad-demm, kliewi)
H319
H317
H410
|
|
orali:
ATE = 500 mg/kg piż tal-ġisem
M = 10
M = 10”
|
|
|
“607-756-00-6
|
akrilat ta’ eżo-1,7,7-trimetilbiċiklo[2.2.1]ept-2-il; akrilat isobornil
|
227-561-6
|
5888-33-5
|
Sens. tal-Ġilda 1 A
|
H317
|
GHS07
Twis.
|
H317”
|
|
|
|
|
“607-757-00-1
|
daminożidu (ISO); aċidu 4-(2,2-dimetilidrażina)-4-ossobutanojku; aċidu N-dimetilamminosuċċinamiko
|
216-485-9
|
1596-84-5
|
Karċ. 2
|
H351
|
GHS08
Twis.
|
H351”
|
|
|
|
|
“607-758-00-7
|
4,4’-ossidi(benżensulfonoidrażid)
|
201-286-1
|
80-51-3
|
Awtoreat. D
Akkwatiku Akut 1
Akkwatiku Kroniku 1
|
H242
H400
H410
|
GHS02
GHS09
Dgr
|
H242
H410
|
|
M = 1
M = 1”
|
|
|
“607-759-00-2
|
toluwen-4-sulfonoidrażid
|
216-407-3
|
1576-35-8
|
Awtoreat. D
|
H242
|
GHS02
Dgr
|
H242”
|
|
|
|
|
“607-760-00-8
|
aċitat 2-[N-etil-4-[(5-nitrotijażol-2-il)ażo]-m-toluidino]etiliku; C.I. Disperse Blue 124
|
239-203-6
|
15141-18-1
|
Sens. tal-Ġilda 1 A
|
H317
|
GHS07
Twis.
|
H317
|
|
Sens. tal-Ġilda 1 A; H317: C ≥ 0,001 %”
|
|
|
“607-761-00-3
|
Aċidu perfluworoettanojku; aċidu tridekafluworoettanojku
|
206-798-9
|
375-85-9
|
Ripr. 1B
STOT RE 1
|
H360D
H372 (fwied)
|
GHS08
Dgr
|
H360D
H372 (fwied)”
|
|
|
|
|
“607-762-00-9
|
metil N-(isopropossikarbonil)-L-valil-(3RS)-3-(4-klorofenil)-β-alaninat; valifenalat
|
-
|
283159-90-0
|
Karċ. 2
Akkwatiku Kroniku 2
|
H351
H411
|
GHS08
GHS09
Twis.
|
H351
H411”
|
|
|
|
|
“607-763-00-4
|
aċidu 6-[C12-18-alkil-(b’fergħat, mhux saturati)-2,5-diossopirrolidin-1-il] eżanojku, sodju u l-imluħ ta’ tris(2-idrossietil) ammonju
|
-
|
-
|
Ripr. 1B
Irrit. tal-Għajnejn 2
|
H360FD
H319
|
GHS08
GHS07
Dgr
|
H360FD
H319”
|
|
|
|
|
“607-764-00-X
|
aċidu 6-[(C10-C13)-alkil-(b’fergħat, mhux saturati)-2,5-diossopirrolidin-1-il]eżanojku
|
-
|
2156592-54-8
|
Ripr. 1B
Irrit. tal-Għajnejn 2
|
H360FD
H319
|
GHS08
GHS07
Dgr
|
H360FD
H319”
|
|
|
|
|
“607-765-00-5
|
aċidu 6-[C12-18-alkil-(b’fergħat, mhux saturati)-2,5-diossopirrolidin-1-il]eżanojku
|
-
|
-
|
Ripr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
|
“613-341-00-0
|
klofenteżina (ISO); 3,6-bis(o-klorofenil)-1,2,4,5-tetrażina
|
277-728-2
|
74115-24-5
|
Akkwatiku Kroniku 1
|
H410
|
GHS09
Twis.
|
H410
|
|
M = 1”
|
|
|
“613-342-00-6
|
teofillina; 1,3-dimetil-3,7-diidro-1H-purina-2,6-dion;
|
200-385-7
|
58-55-9
|
Ripr. 1B
|
H360D
|
GHS08
Dgr
|
H360D”
|
|
|
|
|
“613-343-00-1
|
piridalil (ISO); etere ta’ 2,6-dikloro-4-(3,3-dikloroallilossi)fenil 3-[5-(trifluworometil)-2-piridilossi]propil
|
-
|
179101-81-6
|
Sens. tal-Ġilda 1
Akkwatiku Akut 1
Akkwatiku Kroniku 1
|
H317
H400
H410
|
GHS07
GHS09
Twis.
|
H317
H410
|
|
M = 1 000
M = 100”
|
|
|
“613-344-00-7
|
Piridina-2-tijol-1-ossidu, melħ tas-sodju; sodju tal-pirition; pirition tas-sodju;
|
223-296-5;
240-062-8
|
3811-73-2;
15922-78-8
|
Toss. Akuta 3
Toss. Akuta 3
Toss. Akuta 4
STOT RE 1
Irrit. tal-Ġilda 2
Irrit. tal-Għajnejn 2
Sens. tal-Ġilda 1
Akkwatiku Akut 1
Akkwatiku Kroniku 2
|
H331
H311
H302
H372 (sistema nervuża)
H315
H319
H317
H400
H411
|
GHS06
GHS08
GHS09
Dgr
|
H331
H311
H302
H372 (sistema nervuża)
H315
H319
H317
H410
|
EUH070
|
inalazzjoni:
ATE = 0,5 mg/L (trabijiet jew raxx)
dermali:
ATE = 790 mg/kg piż tal-ġisem
orali:
ATE = 500 mg/kg piż tal-ġisem
M = 100”
|
|
|
“613-345-00-2
|
1,3,5-triażina-2,4,6-triamina;
melamina
|
203-615-4
|
108-78-1
|
Karċ. 2
STOT RE 2
|
H351
H373 (kanal tal-awrina)
|
GHS08
Twis.
|
H351
H373 (kanal tal-awrina)”
|
|
|
|
|
“615-046-00-2
|
1,3-bis(1-isoċjanato-1-metiletil)benżen; [m-TMXDI]
|
220-474-4
|
2778-42-9
|
Sens. Resp. 1
Sens. tal-Ġilda 1 A
|
H334
H317
|
GHS08
Dgr
|
H334
H317”
|
|
|
|
|
“615-047-00-8
|
1,3-bis(isoċjanatometil)benżen; [m-XDI]
|
222-852-4
|
3634-83-1
|
Sens. Resp. 1
Sens. tal-Ġilda 1 A
|
H334
H317
|
GHS08
Dgr
|
H334
H317
|
|
Sens. tal-Ġilda 1 A; H317: C ≥ 0,001 %”
|
|
|
“615-048-00-3
|
diisoċjanat ta’ 2,4,6-triisopropil-m-fenilen
|
218-485-4
|
2162-73-4
|
Sens. Resp. 1
Sens. tal-Ġilda 1
|
H334
H317
|
GHS08
Dgr
|
H334
H317”
|
|
|
|
|
“615-049-00-9
|
1,5-naftilen diisoċjanat
[li fih < 0,1 % (w/w) ta’ partikoli b’dijametru ajrudinamiku ta’ inqas minn 50 μm]
|
221-641-4
|
3173-72-6
|
STOT SE 3
Irrit. tal-Ġilda 2
Irrit. tal-Għajnejn 2
Sens. Resp. 1
Sens. tal-Ġilda 1 A
Akkwatiku Kroniku 3
|
H335
H315
H319
H334
H317
H412
|
GHS07
GHS08
Dgr
|
H335
H315
H319
H334
H317
H412”
|
|
|
|
|
“615-050-00-4
|
diisoċjanat ta’ 1,5-naftilen
[li fih < 0,1 % (w/w) ta’ partikoli b’dijametru ajrudinamiku ta’ inqas minn 50 μm]
|
221-641-4
|
3173-72-6
|
Toss. Akuta 2
STOT SE 3
Irrit. tal-Ġilda 2
Irrit. tal-Għajnejn 2
Sens. Resp. 1
Sens. tal-Ġilda 1 A
Akkwatiku Kroniku 3
|
H330
H335
H315
H319
H334
H317
H412
|
GHS06
GHS08
Dgr
|
H330
H335
H315
H319
H334
H317
H412
|
|
inalazzjoni:
ATE = 0,27 mg/L (trabijiet jew raxx)”
|
|
|
“616-237-00-3
|
fluwopikolid (ISO); 2,6-dikloro-N-[3-kloro-5-(trifluworometil)-2-piridilmetil]benżammid
|
-
|
239110-15-7
|
Ripr. 2
|
H361d
|
GHS08
Twis.
|
H361d”
|
|
|
|
|
“616-238-00-9
|
triammid N-(2-nitrofenil)fosforiku
|
477-690-9
|
874819-71-3
|
Ripr. 1B
STOT RE 2
|
H360Fd
H373 (kliewi)
|
GHS08
Dgr
|
H360Fd
H373 (kliewi)”
|
|
|
|
|
“616-239-00-4
|
N-(5-kloro-2-isopropilbenżil)-N-ċiklopropil-3-(difluworometil)-5-fluworo-1-metil-1H-pirażol-4-karbossammid; isofluċipram
|
-
|
1255734-28-1
|
Ripr. 2
Toss. Akuta 4
Sens. tal-Ġilda 1B
Akkwatiku Akut 1
Akkwatiku Kroniku 1
|
H361f
H332
H317
H400
H410
|
GHS08
GHS07
GHS09
Twis.
|
H361f
H332
H317
H410
|
|
inalazzjoni:
ATE = 2,2 mg/L (trabijiet jew raxx)
M = 10
M = 1”
|
|
|
“616-240-00-X
|
Massa ta’ reazzjoni ta’ 3-(difluworometil)-1-metil-N-[(1RS,4SR,9RS)-1,2,3,4-tetraidro-9-isopropil-1,4-metanonaftalen-5-il]pirażol-4-karboksammid u 3-(difluworometil)-1-metil-N-[(1RS,4SR,9SR)-1,2,3,4-tetraidro-9-isopropil-1,4-metanonaftalen-5-il]pirażol-4-karboksammid [kontenut relattiv ≥ 78 % sin isomeri ≤ 15 % anti isomeri]; isopirażam
|
-
|
881685-58-1
|
Karċ. 2
Ripr. 1B
Sens. tal-Ġilda 1B
Akkwatiku Akut 1 Akkwatiku Kroniku 1
|
H351
H360D
H317
H400
H410
|
GHS08
GHS07
GHS09
Dgr
|
H351
H360D
H317
H410
|
|
Ripr. 1B; H360D:
C ≥ 3 %
M = 10
M = 10”
|
|
|
“650-058-00-1
|
Margosa, ext. [mill-ħabb tal-Azadirachta indica estratta bl-ilma u proċessata ulterjorment b’solventi organiċi]
|
283-644-7
|
84696-25-3
|
Ripr. 2
Sens. tal-Ġilda 1
Akkwatiku Kroniku 1
|
H361d
H317
H410
|
GHS08
GHS07
GHS09
Twis.
|
H361d
H317
H410
|
|
M = 10”
|
|